Physician profile
Jacques E Gaudet
NPI 1750573994
$5,420.96
in general payments reported to CMS, 2019-2025
26 companies · $847 in 2025
The $847 reported for 2025 was more than what 76% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,754 · 2020: $473 · 2021: $367 · 2022: $524 · 2023: $954 · 2024: $501 · 2025: $847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,302.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $2,024.01 | 2019-2024 | |
| Acclarent, INC | $1,109.02 | 2019-2024 | Trudi Nav Cable, Spine & Trauma 3d Navigation, Acclarent Navwire |
| Optinose US, INC. | $435.64 | 2019-2025 | |
| Glaxosmithkline, LLC. | $358.97 | 2020-2025 | Nucala |
| Stryker Corporation | $248.59 | 2019-2025 | Scopis Ent |
| Organogenesis INC. | $160.53 | 2022-2025 | Affinity, Via Matrix |
| Regeneron Healthcare Solutions, INC. | $135.94 | 2022-2024 | Dupixent |
| Inspire Medical Systems, INC. | $122.13 | 2025 | Inspire |
| Genzyme Corporation | $113.64 | 2021-2025 | |
| Spirair, INC. | $83.95 | 2024-2025 | Septalign |
| Phadia US INC. | $83.30 | 2023 | Immunocap |
| Smith+Nephew, INC. | $75.68 | 2024-2025 | Stravix, Grafix Pl, Stravix Pl |
| Hill Dermaceuticals, INC. | $65.42 | 2023-2024 | Tolak |
| Hikma Pharmaceuticals USA | $51.22 | 2024-2025 | Ryaltris |
| Acera Surgical, INC. | $45.18 | 2025 | Restrata Wound Matrix |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $43.43 | 2021 | |
| Abbvie INC. | $39.16 | 2025 | |
| Tactile Systems Technology INC | $36.01 | 2021-2022 | |
| Integra Lifesciences Corporation | $34.84 | 2024 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Astrazeneca Pharmaceuticals Lp | $34.74 | 2022 | |
| Cochlear Americas | $26.73 | 2022 | |
| Davol INC. | $25.01 | 2023 | Arista Ah Flexitip |
| Intersect Ent, INC. | $19.70 | 2021 | |
| Apria Healthcare LLC | $18.66 | 2021 | |
| Merck Sharp & Dohme LLC | $15.17 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $14.29 | 2023 | Iovera, Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacques Gaudet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.